Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme Phenotype
Background: Some glioblastoma multiforme (GBM) are characterized by the presence of gemistocytes (GCs), a unique phenotype of reactive astrocytes. Certain GCs can be identified as neoplastic cells but these cells were also found to be associated with diabetes in non-neoplastic lesions of the central...
Main Authors: | Yosef Laviv, Eilat Sapirstein, Andrew A Kanner, Shani Berkowitz, Suzana Fichman, Alexandra Benouaich-Amiel, Shlomit Yust-Katz, Ekkehard E Kasper, Tali Siegal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-10-01
|
Series: | Clinical Pathology |
Online Access: | https://doi.org/10.1177/2632010X231207725 |
Similar Items
-
Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study
by: Orit Uziel, et al.
Published: (2024-01-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Unraveling unique and common cell type-specific mechanisms in glioblastoma multiforme
by: Samreen Fathima, et al.
Published: (2022-01-01) -
Advances in immunotherapy for glioblastoma multiforme
by: Ahmad Bakur Mahmoud, et al.
Published: (2022-10-01)